title: Enhanced working and verbal memory after lamotrigine treatment in pediatric bipolar disorder.
abstract: OBJECTIVE
  To examine the treatment impact of lamotrigine on the neurocognitive profile of patients with pediatric bipolar disorder (PBD).
  
  
  METHODS
  Healthy controls (HC) (n = 24; mean age = 12.4 +/- 3.3 years) and unmedicated PBD patients with manic, mixed, or hypomanic episodes (n = 34; mean age = 13 +/- 3.1 years) were matched for IQ, age, sex, race, and socioeconomic status. A neurocognitive battery was administered at baseline and again after 14 weeks, during which PBD patients were treated with lamotrigine.
  
  
  RESULTS
  Clinical symptoms improved with treatment in the patient group with significant change from baseline to follow-up on the Young Mania Rating Scale (p < 0.001) and the Children's Depression Rating Scale-Revised (p < 0.001). Global neurocognitive function improved with lamotrigine in PBD patients over time relative to that in HC, although overall performance remained impaired. Working memory and verbal memory significantly improved with treatment in patients, and deficits in these domains were no longer significantly impaired relative to HC at follow-up. Executive function significantly improved with treatment in the patient group but still lagged behind HC at follow-up. Performance on attention tests did not improve with treatment.
  
  
  CONCLUSIONS
  There appears to be significant improvement in cognitive abilities in PBD patients treated with lamotrigine that is most prominent in the areas of working memory and verbal memory and that occurs along with mood stabilization.
authors.affiliation: Center for Cognitive Medicine, University of Illinois Medical Center at Chicago, Chicago, IL 60612, USA. mpavuluri@psych.uic.edu
authors.forename: Mani N
authors.initials: MN
authors.lastname: Pavuluri
authors.forename: Alessandra M
authors.initials: AM
authors.lastname: Passarotti
authors.forename: Tahseen
authors.initials: T
authors.lastname: Mohammed
authors.forename: Julie A
authors.initials: JA
authors.lastname: Carbray
authors.forename: John A
authors.initials: JA
authors.lastname: Sweeney
mesh_terms: D000293:Adolescent; D001288:Attention / Q000187:drug effects; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D016022:Case-Control Studies; D002648:Child; D003071:Cognition / Q000187:drug effects*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D056344:Executive Function / Q000187:drug effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008568:Memory / Q000187:drug effects*; D008570:Memory, Short-Term / Q000187:drug effects; D009483:Neuropsychological Tests; D016896:Treatment Outcome; D014227:Triazines / Q000627:therapeutic use*; D014706:Verbal Learning / Q000187:drug effects
chemical_list: D002121:Calcium Channel Blockers; D014227:Triazines; D000077213:Lamotrigine
references.citation: J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):299-307
references.pmid: 19182689
references.citation: Biol Psychiatry. 2004 Jan 1;55(1):32-9
references.pmid: 14706422
references.citation: MedGenMed. 2006 Aug 23;8(3):46
references.pmid: 17406176
references.citation: J Clin Psychopharmacol. 2006 Apr;26(2):178-81
references.pmid: 16633148
references.citation: Neurology. 1999 Jan 15;52(2):321-7
references.pmid: 9932951
references.citation: J Clin Psychiatry. 2004 Nov;65(11):1483-90
references.pmid: 15554760
references.citation: Pflugers Arch. 1995 Jul;430(3):437-46
references.pmid: 7491269
references.citation: J Affect Disord. 1998 Nov;51(2):93-100
references.pmid: 10743842
references.citation: Biol Psychiatry. 2000 Oct 1;48(7):674-84
references.pmid: 11032979
references.citation: Epilepsia. 2006 Apr;47(4):695-703
references.pmid: 16650135
references.citation: Am J Psychiatry. 2006 Feb;163(2):286-93
references.pmid: 16449483
references.citation: Epilepsia. 1986 Sep-Oct;27(5):490-7
references.pmid: 3757936
references.citation: J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):107-125
references.pmid: 17195735
references.citation: Neuropsychopharmacology. 2001 Nov;25(5):766-76
references.pmid: 11682260
references.citation: Synapse. 1996 Nov;24(3):248-55
references.pmid: 8923665
references.citation: J Am Acad Child Psychiatry. 1984 Mar;23(2):191-7
references.pmid: 6715741
references.citation: Biol Psychiatry. 2006 Nov 1;60(9):951-6
references.pmid: 16730333
references.citation: J Am Acad Child Adolesc Psychiatry. 2006 Feb;45(2):142-148
references.pmid: 16429084
references.citation: J Consult Clin Psychol. 2007 Apr;75(2):210-20
references.pmid: 17469879
references.citation: Am J Psychiatry. 2005 Sep;162(9):1644-51
references.pmid: 16135623
references.citation: Br J Psychiatry. 1999 Sep;175:246-51
references.pmid: 10645326
references.citation: Epilepsia. 2002 Jan;43(1):19-26
references.pmid: 11879382
references.citation: Br J Psychiatry. 1978 Nov;133:429-35
references.pmid: 728692
references.citation: Neurology. 2006 May 23;66(10):1495-9
references.pmid: 16717207
references.citation: Br J Psychiatry. 2002 Apr;180:293-5
references.pmid: 11925348
references.citation: Dev Psychopathol. 2006 Fall;18(4):1231-46
references.pmid: 17064436
references.citation: Neurology. 2001 May 8;56(9):1177-82
references.pmid: 11342682
references.citation: Biol Psychiatry. 2005 Oct 1;58(7):540-8
references.pmid: 16199011
references.citation: Eur Neuropsychopharmacol. 2008 Jan;18(1):48-54
references.pmid: 17618089
references.citation: J Clin Psychopharmacol. 2007 Aug;27(4):387-91
references.pmid: 17679147
references.citation: J Am Acad Child Adolesc Psychiatry. 2007 Mar;46(3):341-355
references.pmid: 17314720